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Abstract  
Introduction: COVID-19 is a zoonotic viral infection that first emerged in Wuhan, China, the source of which 
is thought to be a seafood market, and then spread rapidly from China to the world. 
Objective: The aim of this observational study was to analyze cases with COVID-19 admitted to a single 
secondary care center in Turkey. 
Methods: This is a descriptive study performed during the period from March 22 to 30, 2020, in Kars Harakani 
State Hospital, Kars, Turkey. We evaluated all patients with reverse transcription polymerase chain 
reaction (RT-PCR) to confirm COVID-19. Demographic characteristics, clinical signs and symptoms, 
comorbidities, blood tests results, chest computed tomography (CT) scan findings and outcomes including 
hospitalization, intensive care unit (ICU) admission and survival of the patients were recorded.  
Results: During the one week study period, we took 435 nasopharyngeal swabs from suspicious cases and 
found 22 patients (4 females, 18 males) whose COVID-19 infection was confirmed via RT-PCR. Their ages 
ranged from 18 to 86 years, with an average of 45.59±25.02. Ten (45%) of the cases were current smokers. 
The body temperature of the cases ranged from 36.1 to 38.4 oC, with an average of 36.78 ± 0.65. Four cases 
were asymptomatic and the most common complaint was cough (82%). Hypertension (23%) and chronic 
obstructive pulmonary disease (COPD) (23%) were the most common coexisting diseases. In chest CT scan, 
ground glass densities were detected in 7 (32%) patients and infiltration was observed in 8 (36.3%). The 
mortality rate of the cases was 9% (n=2). 
Conclusion: The most common complaint of patients was cough. Hypertension and COPD were the most 
prevalent comorbidities among patients. 
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INTRODUCTION
COVID-19 is a zoonotic viral infection that first 
emerged in Wuhan, China, the source of which is 
thought to be a seafood market, and then spread 
rapidly from China to the world (1, 2). The clinical 
spectrum of COVID-19 ranges from asymptomatic 
cases to severe viral pneumonia, acute respiratory 
distress syndrome and death (2, 3). The first positive 
case of COVID-19 in Turkey was announced on 
March 11, 2020 and the patient had travelled to 
Europe. The statistics regarding COVID-19 patients 
in Turkey until April 15, 2020 are as follows: total 
number of tests performed 443,626; number of 
positive cases 65,111; number of deaths 1,403; 
number of cases admitted to intensive care unit 
(ICU) 1,809; number of intubated patients 1,087; 
number of cases recovered from the disease 4,799 
(4). Here, we present the clinical characteristics of 
patients with confirmed COVID-19, who were 
diagnosed and treated in a secondary care center in 
Turkey.  
Methods 
This descriptive study was performed during the 
period from March 22 to 30, 2020, in Kars Harakani 
State Hospital, Kars, Turkey. the standard protocol 
of th ehospital, which was used for evaluating the 
patients is as follows: The body temperature of all 
patients admitted to the emergency department 
(ED) is first measured in triage. Patients with 
complaints of fever, cough or sputum are 
considered as suspected patients for COVID-19. 
Suspected patients are taken to the isolation room 
in the ED by the triage nurse. Suspected patients 
are re-evaluated by the doctor and the following 
items are assessed: a) either of the signs or 
symptoms including fever or lower respiratory 
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disease findings (cough, sputum) are present, b) 
the clinical picture cannot be explained by another 
disease, c) his/her relatives or himself/herself 
have travelled abroad within 14 days before the 
onset of symptoms, d) he/she has been in close 
contact with a confirmed case of COVID-19 within 
14 days before the onset of symptoms. The criteria 
for identifying those who are At risk of developing 
COVID-19: a) health workers providing care 
without using proper protective equipment for 
COVID-19, b) people sharing the same class, room, 
office, hotel with COVID-19 patients, c) those 
shaking hands with the patients, c) people who 
remain face to face with the cases for more than 15 
minutes in less than one meter distance, d) people 
who have travelled with the COVID-19 patient on 
the same plane (two people in the front, two in the 
back, two on the right and two on the left). 
We evaluated all patients using reverse 
transcription polymerase chain reaction (RT-
PCR) to confirm COVID-19 infection. For this 
purpose, a nasopharyngeal swab sample was taken 
from those identified as suspected cases by the 
doctor and chest computed tomography (CT) scan 
was planned according to the clinical findings. 
Demographic characteristics, clinical signs and 
symptoms, comorbidities, blood tests results, chest 
CT scan findings and outcomes including 
hospitalization, intensive care unit (ICU) admission 
and survival of the patients were recorded. Cases 
were numbered as C1 (case 1)-C22 (case 22) from 
1 to 22. 
RESULTS 
During the one week study period, we took 435 
nasopharyngeal swab samples from suspected 
cases and we evaluated the 22 patients whose 
COVID-19 infection was confirmed via RT-PCR in 
the hospital. Four of the patients were female 
(18%) and 18 were male (82%). The age of the 
patients ranged from 18 to 86 years, with an 
average of 45.59±25.02. One of the patients had 
returned from Mecca, Saudi Arabia and this case 
was the only case with international contact among 
our patients (C12). One patient was pregnant 
(C2).10 (45%) of the cases were current smokers, 
6 (27.5%) were non-smokers and 6 were ex-
smokers (27.5%). Cases 8-10 were living in the 
same house. None of the patients stayed in the 
nursing home or were homeless. The body 
temperature of the cases ranged from 36.1 to 
38.4°C, with an average of 36.78 ± 0.65. The 
respiratory rate of the patients ranged between 16 
and 30 per minute with an average of 20.18 ± 3.54. 
The systolic blood pressure of cases varied 
between 100 and 140 mmHg, with an average of 
Table 1: Clinical symptoms and signs of the study patients 
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C1 - + - + - - - - - - - 
C2 - + + - - - - - - - - 
C3 - + - + - - - - - - - 
C4 - + + - - - + - - - - 
C5 - + - - - - - + - - - 
C6 - + - - - - - - - - - 
C7 - + - - - - - - - - - 
C8 - + - + + - + - - - - 
C9 + - - - - - - - - - - 
C10 + - - - - - - - - - - 
C11 + - - - - - - - - - - 
C12 - + + + - - - - - - - 
C13 - + - - - - + - - - - 
C14 - + - + + + - - - - - 
C15 - + - + - - - - - - - 
C16 - + + + - - - - - - - 
C17 + - - - - - - - - - - 
C18 - + - - - - - - - - - 
C19 - + - - - - + - + - - 
C20 - + - - - - + - - - - 
C21 - + - - - - - - - - - 
C22 - + - + - + - - - - - 
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114.09 ± 10.98. The heart rate of the cases varied 
between 68 and 120 per minute, with an average of 
87.36 ± 12.92. The oxygen saturation of the cases 
ranged between 80% and 98% in room air, with an 
average of 91.72±5.61. Clinical symptoms and signs 
of patients are given in table 1. Four cases were 
asymptomatic and the most common complaint 
was cough (82%). Comorbidities of the patients are 
given in table 2. Hypertension (23%) and chronic 
obstructive pulmonary disease (COPD) (23%) 
were the most common coexisting diseases among 
patients, followed by coronary artery disease 
(CAD) (18%), congestive heart failure (CHF) 
(18%), diabetes mellitus (DM) (9%), asthma 
(4.5%) and neoplastic disease including chronic 
lymphocytic leukemia (CLL) (4.5%). Blood test 
results of patients including renal functions (urea, 
creatinine), liver tests (alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), total 
bilirubine, sodium, glucose, c-reactive protein 
(CRP) and complete blood counts (white blood cell 
(WBC), neutrophil, hemoglobine, platelets) are 
demonstrated in table 3. Chest CT findings and 
outcomes of the cases are presented in table 4. Only 
one patient had pleural effusion (C13). Ground 
glass densities were detected in 7 (32%) patients 
Table 2: Comorbidities of the study patients 
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C12 + - - - + - - - - - - 
C13 + + - - + - - - - - - 
C14 + - - + + - - - + - - 
C15 - - - - + - - - - - - 
C16 - - - - - - - - - - - 
C17 - - - - - - - - - - - 
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C22 + - - + + - - - + - - 
 
Table 3: Blood test results of study patients (n=22) 
Blood test Minimum Maximum Mean±SD 
Urea, mg/dL 10 86 35.65±17.99 
Creatinine, mg/dL 0.47 1.60 0.99±0.26 
Aspartate aminotransferase, U/L 10.7 137 30.17±27.84 
Alanine aminotransferase, U/L 8.90 81.10 22.55±17.76 
Total bilirubin, mg/dL 0.21 2.79 0.84±0.57 
Sodium, mmol/L 132 142 138.45±2.63 
Glucose, mg/dL 79.4 251 106.01±35.9 
C-reactive protein, mg/L 1 87.12 16.49±23.22 
White blood cell, 10*3/uL 5.25 14.81 9.46±2.84 
Hemoglobin, g/dL 9 17.6 14.52±2.40 
Neutrophil, 10*3/uL 2.54 11.70 6.54±2.78 
Platelet, 10*3/uL 30 339 215.5±66.99 
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and infiltration was observed in 8 (36.3%). Only 
one patient (C3) was admitted to the ICU and the 
others were hospitalized. The mortality rate of the 
cases was 9% (n=2). One patient died suddenly 
during hospitalization (C22) and the only patient 
admitted to ICU died on the fifth day (C3). This 
patient (C3) who died in ICU had 
thrombocytopenia and CLL.  
DISCUSSION 
All 22 patients in this case series were diagnosed in 
a secondary care center and the majority of them 
had moderate COVID-19. In the study, our patients 
were generally middle-aged (45.59±25.02) men 
(82%). The fact that middle-aged men are more 
active in working life may be the most important 
reason for rapid transmission/the higher 
prevalence of COVID-19 among them. The curfew 
for citizens over 65 years in Turkey may be another 
reason for the low average age. Turkey has stopped 
flights to China on February 3, to Iran on February 
23, to Iraq, Italy and South Korea on February 29, 
2020. Minister of Health of the Republic of Turkey 
has announced the first COVID-19 patient on March 
11, 2020. On March 13, Turkey also stopped flights 
to Europe. These preventive measures were taken 
to reduce contamination from abroad. Our unique 
patient/One of our patients had been to Mecca, 
Saudi Arabia for umrah and he was the only patient 
who had cross-border contact among our cases. 
The Kingdom of Saudi Arabia has declared the first 
COVID-19 patient on March 2, 2020. Taking 
precautions to prevent contact with countries 
where COVID-19 spread rapidly resulted in 
delayed emergence of this disease in Turkey. 
Smoking was common among our patients (45%). 
Cigarette smoke and its contents may cause 
impairment of mucociliary clearance in the 
respiratory epithelium, peribronchiolar 
inflammation and fibrosis, and increased mucosal 
permeability. Smoking can also repress protection 
of respiratory epithelium, alveolar macrophages, 
dendritic cells and adaptive immune mechanisms; 
and as a result, smoking precipitates to lower 
respiratory infections (5, 6). 
The most prevalent symptoms of COVID-19 were 
fever, cough, fatigue, sputum, shortness of breath, 
sore throat and headache, respectively (7). 
However, the most common symptom among our 
patients was cough (82%). The mean fever/body 
temperature of the patients was not high (36.78 ± 
0.65) and the highest temperature measured was 
Table 4: Chest computed tomography scan findings and outcomes of the study patients 
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C18 - - - - - - - - - - + - - 
C19 - - - - - - - - - - + - - 
C20 - - - - - - - - - - + - - 
C21 - - - - - - - - - - + - - 
C22 - + - - - - - + - + + - + 
ICU: intensive care unit 
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38oC. Mean systolic blood pressure 
(114.09±10.98), heart rate (87.36 ± 12.92) and 
oxygen saturation (91.72±5.61) indicated that 
patients were hemodynamically stable at the time 
of admission to the hospital. Comorbidity is a risk 
factor for COVID-19, which also increases the 
severity and mortality of the disease (8, 9). We found 
that the most common chronic disease among our 
patients was hypertension, which was in line with 
the literature, but COPD was as common as 
hypertension. In COVID-19 patients, ground glass 
opacities and consolidations are the main 
characteristics of chest tomography and our results 
were also similar to the these findings (10, 11).  
CONCLUSIONS 
The majority of our patients were middle-aged 
men. Cough was a more common symptom than 
fever. hypertension  and COPD were the most 
common comorbidities among patients with 
COVID-19. 
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